Showing 571-580 of 1378 results for "".
- Dr. Jason Bloom Shares Latest Innovations from Korean Skincare on Philadelphia Newscasthttps://modernaesthetics.com/news/dr-jason-bloom-shares-latest-skincare-innovations-from-korean-skincare/2473702/Korean skincare, also known as K-Beauty, has become increasingly popular in the United States as Americans look to achieve “glass” skin. Social media, particularly TikTok, has played a large role in promoting K-Beauty lines and products. Jason Bloom, MD, is the founder
- DefenAge Skincare Launches 12-Factor Revitalizing Lip Enhancerhttps://modernaesthetics.com/news/defenage-skincare-launches-12-factor-revitalizing-lip-enhancer/2473701/DefenAge Skincare introduces a “revolutionary, first-of-its kind” anti-aging serum for fuller, smoother and more youthful lips. The 12-Factor Revitalizing Lip Enhancer is powered by DefenAge’s patented Age-Repair Defensins. The lip serum is designed to rejuvenate lip a
- New Data Demonstrates Long-Term Safety, Efficacy of Galderma’s RelabotulinumtoxinAhttps://modernaesthetics.com/news/new-data-demonstrates-long-term-safety-efficacy-of-galdermas-relabotulinumtoxina/2473698/Galderma presented new phase III data from the READY-4 clinical trial at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting last week. The data demonstrates the long-term safety of RelabotulinumtoxinA (RelfydessTM) for frown lines and crow’s feet after repea
- JOYA Launches First Skin Cancer Prevention, Anti-Aging Employee Benefit Platformhttps://modernaesthetics.com/news/joya-launches-first-skin-cancer-prevention-anti-aging-employee-benefit-platform/2473695/JOYA the first employee skin health and wellness benefit platform, announced its emergence from stealth mode with $5 million in seed funding from LUX Capital, Mosaic General Partnership, Arsama Trust, and Joyance Partners. The funding will support team expansion, product developme
- FDA Clears Accure Laser System for Acne Vulgarishttps://modernaesthetics.com/news/fda-clears-accure-laser-system-for-acne-vulgaris/2473691/The US Food and Drug Administration (FDA) cleared the Accure Laser System for the long-term treatment of patients with mild-to-severe inflammatory acne vulgaris, according to a press release from Accure Acne, Inc. "This achievement cannot be overstated," Acclure Acne co-founde
- Cetaphil Launches Rebrand with Debut of ‘For Everyone’s Sensitive Skin’ Campaignhttps://modernaesthetics.com/news/cetaphil-launches-rebrand-with-debut-of-for-everyones-sensitive-skin-campaign/2473689/A popular skincare line debuts “For Everyone’s Sensitive Skin” campaign as part of a rebrand. Cetaphil announced a complete brand “restage,” in a press release earlier this week. The brand is revamping its 77-year-old image with a bold, refreshed visual upgrade. 
- Swollen Lip Following Filler Procedure Leads to Woman Being Diagnosed With Leukemiahttps://modernaesthetics.com/news/swollen-lip-following-filler-procedure-leads-to-woman-being-diagnosed-with-leukemia/2473688/An unexpected swollen lip during a lip filler procedure led a British woman to discover she had leukemia. In April 2023, Edita Jucaite, 36, was getting a dermal filler procedure and when it was injected into her lip it immediately swelled up. Jucaite was modeling for a dentist col
- Epicutis® Launches Arctigenin Brightening Treatmenthttps://modernaesthetics.com/news/epicutis-launches-arctigenin-brightening-treatment/2473684/The newest addition to Epicutis’s science-based professional skincare line, which the company says treats skin health and not age, is the Arctigenin Brightening Treatment—a clean, clinically proven skin brightening treatment that Epicutis says dethrones Vitamin C as the reigning brigh
- New Noninvasive Treatment Boasts Long-Lasting Lift, Zero Downtimehttps://modernaesthetics.com/news/new-noninvasive-treatment-boasts-long-lasting-lift-zero-downtime/2473674/Merz Aesthetics announced the launch of Ultherapy PRIME, a noninvasive treatment that the company says provides a truly personalized and long-lasting lift of the skin in one session with zero downtime. “The Ultherapy PRIME platform is the evolution of Ultherapy®, which has bee
- Research Shows Dermatology Lasers Market to See Strong Growth By 2028https://modernaesthetics.com/news/research-shows-dermatology-lasers-market-to-see-strong-growth-by-2028/2473671/The dermatology lasers market is forecasted to grow to $2.88 billion in 2028. During the forecasted period from 2024 to 2028, the Business Research Company reports the industry will increase at a compound annual growth rate of 7%. An increase in skin cancer cases is one of the top